Medical Store Opening Made Easy In UP

Lucknow:  While granting a license to open a pharmaceutical company and sell medicines, entrepreneurs will no longer be subjected to rules like size of the firm, investment, domestic or foreign investor and business risk like other businesses.

Due to its inclusion in Invest UP’s Business Reform Action Plan (BRAP)-2024, entrepreneurs are facing difficulties in getting licenses. In such a situation, the Food Safety and Drug Administration Department has written a letter demanding exemption from this.

While granting license for setting up a pharmaceutical company or for sale of medicines under the Drug and Cosmetic Act, only the storage capacity as per standards, facility to keep medicines at low temperature and registration of pharmacist are considered.

According to BRAP-2024 of Invest UP, the Food Safety and Drug Administration Department has already made arrangements for granting and monitoring licenses through an online portal. There is also a system to deposit fees online for the license and to see with which officer the file is pending or everything online.

In such a situation, Principal Secretary, Food Safety and Drug Administration P. Guruprasad sent a letter to the Chief Executive Officer of Invest UP demanding exemption from rules like size of firm etc. under BRAP, because there is no provision for this in the Drug and Cosmetic Act, hence it cannot be implemented. At present, after getting the exemption, the drug entrepreneurs will get a lot of relief.

Related Posts

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

The Team Meticulously averted the Risk of Thrombosis, Husband was Donor Delhi/NCR : Doctors at Yashoda Medicity have successfully performed a high-risk kidney transplant in a 28-year-old woman with Antiphospholipid…

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta, a UK-based clinical stage biotech, is differentiated clinical-stage oncology specialist, increasingly defined by continuing progress with its second-generation pre|CISION tumour-activated Peptide Drug Conjugate (PDC) platform. The lead Gen Two…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Puresta launches EVERQ, AI-powered skin-health platform

Puresta launches EVERQ, AI-powered skin-health platform

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell therapy for autism only in approved clinical trials: Centre